IL18 and macrophage activation syndrome: In an expanded dataset on Dutch SJIA patients prospectively recruited with (n = 44) and without (n = 22) arthritis, patients without arthritis trended non-significantly higher in laboratory features associated with MAS, including sIL-2R, but with comparable IL-18 levels at onset.